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Excretion of Avenanthramides, Phenolic Acids and their
Major Metabolites Following Intake of Oat Bran
Manuel Y. Scha¨r, Giulia Corona, Gulten Soycan, Clemence Dine, Angelika Kristek,
Sarah N. S. Alsharif, Volker Behrends, Alison Lovegrove, Peter R. Shewry,
and Jeremy P. E. Spencer*
Scope: Wholegrain has been associated with reduced chronic disease
mortality, with oat intake particularly notable for lowering blood cholesterol
and glycemia. To better understand the complex nutrient proﬁle of oats, we
studied urinary excretion of phenolic acids and avenanthramides after
ingestion of oat bran in humans.
Methods and results: After a 2-d (poly)phenol-low diet, seven healthy men
provided urine 12 h before and 48 h after consuming 60 g oat bran (7.8 μmol
avenanthramides, 139.2 μmol phenolic acids) or a phenolic-low (traces of
phenolics) control in a crossover design. Analysis by ultra-high performance
liquid chromatography (UPLC)–MS/MS showed that oat bran intake resulted
in an elevation in urinary excretion of 30 phenolics relative to the control,
suggesting that they are oat bran-derived. Mean excretion levels were elevated
between 0–2 and 4–8 h, following oat bran intake, and amounted to a total of
33.7 ± 7.3 μmol total excretion (mean recovery: 22.9 ± 5.0%), relative to
control. The predominant metabolites included: vanillic acid, 4- and
3-hydroxyhippuric acids, and sulfate-conjugates of benzoic and ferulic acids,
which accounted collectively for two thirds of total excretion.
Conclusion: Oat bran phenolics follow a relatively rapid urinary excretion,
with 30 metabolites excreted within 8 h of intake. These levels of excretion
suggest that bound phenolics are, in part, rapidly released by the microbiota.
1. Introduction
Increasing the daily intake of wholegrain cereals by 90 g has
been associated with reduction in mortality from cardiovascu-
lar disease by 27%, total cancer by 15%, respiratory disease by
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22%, diabetes by 51%, and infectious
diseases by 26%, as indicated by re-
cent meta-analysis of 45 prospective
studies.[1] Human intervention stud-
ies have to date largely focused on
wholegrain oats (Avena sativa L.), with
meta-analyses establishing that regular
oat intake lowers blood cholesterol[2,3]
and improves insulin sensitivity and
postprandial glycemic control.[4] Al-
though oats only account for 1% of world
grain production, they, unlike more
widely consumed grains, are almost
exclusively consumed as wholegrains
and therefore a rich dietary source
of high quality proteins, minerals,
vitamins, soluble β-glucan ﬁber, and
phenolic compounds (i.e. phenolic acids
and avenanthramides), all of which are
concentrated in the outer bran layers.[5]
β-glucan is, at least in part, responsible
for the health beneﬁts of oats,[2–4] while
there is limited in vitro evidence that
avenanthramides[6] and phenolic acids[7]
may also promote beneﬁcial cardiovas-
cular physiology. Phenolic acid intake
in Europe is on average 605 mg d−1,
with the main dietary sources being coﬀee (75%), fruits (5.6%),
and wholegrain products (5.5%).[8] Wholegrain is the richest di-
etary source of ferulic acid, which has amean intake of 38mg d−1
in Europe,[8] although a number of other phenolic acids and phe-
nolic alkaloids, notably the avananthramides, are present in oats,
either in the ‘‘free form’’, as soluble conjugates, or as insoluble
bound forms (including ester linked to ﬁber).[9] Understanding
the urinary excretion (an indirect measure of absorption) of oat
phenolic compounds following the dietary intake of whole oats
or oat bran is a key prerequisite for determining which phenolic
metabolites may mediate the health beneﬁts of oats.
Previous data using oat phenolic extracts or wheat have indi-
cated phenolics transfer to the circulation following intake,[10,11]
while limited data exist for the urinary excretion of phenolics and
other bioactive components from whole oats or oat bran at a di-
etary level. Notably, the intake of 150 mg of avananthramides
(highly concentrated oat extract), led to detection of avenan-
thramides 2c, 2f, and 2p at nanomolar concentrations in plasma
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between 0.25 and 5 h, peaking at 2 h.[11] While this study did not
examine metabolism, data from studies in animals suggest that
avenanthramide 2c is metabolized to avenanthramide 2f, dihy-
droavenanthramide 2f and 2c, four hydroxycinnamic acids, and
5-hydroxyanthranilic acid following oral intake.[12] Furthermore,
intake of 94 g wholegrain wheat bread, containing 87 mg of fer-
ulic acid or aleurone-enriched white bread led to the appearance
of ferulic acid-sulfate, dihydroferulic-sulfate, hippuric acid, and
two hydroxyhippuric acids in plasma, with the former two reach-
ing peak plasma concentrations of 84 nm and 9 nm at 1 and
7 h after intake, respectively,[10] along with 12 other phenolic acid
metabolites in 48 h urine, suggesting that ferulic acid is subject
to extensive metabolism and that some ﬁber-linked ferulic acid
is released later during transit through the gastrointestinal tract
through action of the microbiota.[10]
The aim of our study was to examine the urinary excre-
tion of avenanthramides and phenolic acids following intake of
60 g oat bran. Speciﬁcally, the study focused on three objectives;
(1) to establish peak urinary excretion intervals of phenolic acids
and avenanthramides; (2) to determine the temporal nature of
oat phenolic release from the bound state in the gastrointesti-
nal tract; and (3) to identify and quantify the range of phenolic
metabolites derived from the oat phenolics using comprehensive
UPLC–MS/MS methods.
2. Experimental Section
2.1. Chemicals and Reagents
Avenanthramide 2c, avenanthramide 2f, avenanthramide 2p, 2,4-
dihydroxy benzoic acid, p-coumaric acid, caﬀeic acid, isoferulic
acid, syringic acid, salicylic acid, o-coumaric acid, vanillic acid, sy-
ringaldehyde, ferulic acid, sinapic acid, 4-hydroxybenzaldehyde,
4-hydroxybenzoic acid, vanillin, protocatechuic acid, isovanil-
lic acid, gallic acid, homovanillic acid, hippuric acid, di-
hydroferulic acid, dihydrocaﬀeic acid, 4-hydroxyphenylacetic
acid, and 2-hydroxyhippuric acid were obtained from Sigma–
Aldrich (see Supporting Information Table S1 for IUPAC
names). Dihydroferulic acid-4-O-glucuronide, isoferulic acid-3-
O-sulfate, ferulic acid-4-O-glucuronide, dihydroxybenzoic acid-
3-O-glucuronide, and 5-hydroxyanthranilic acid were obtained
from Toronto Research Chemicals Inc. 4-Hydroxyhippuric acid
and 3-hydroxyhippuric acid were purchased from Enamine (see
Supporting Information Table S1 for IUPACnames). All solvents
were HPLC grade and were obtained from Sigma–Aldrich or
Fisher Scientiﬁc. While we acknowledge that avenanthramides
are phenolic alkaloids, the terms phenolics is used through-
out the paper to include both avenanthramides and phenolic
acids.
2.2. Extraction and Analysis of Oat Bran Phenolics
Soluble and bound phenolic fractions were extracted from oats
using an establishedmethod,[13] with addition of hexane defatting
steps adapted from[14] and preservation of phenolics during alkali
hydrolysis using ascorbate and EDTA adapted from.[15] Phenolic
acids and avenanthramides were separated using an Agilent 1100
series HPLC equipped with a Kinetex biphenyl column (100 A˚
250 × 4.6 mm, 5μm; Phenomenex) with a Security Guard ultra-
biphenyl cartridge (Phenomenex). Sample injection volume was
20 μL, the ﬂow rate 1 mL min−1, and mobile phases consisted of
0.1% formic acid v/v in water (solvent A) and 0.1% formic acid
v/v inmethanol (solvent B). The solvent gradient consisted of 5%
B at 0 min, 25% B at 20 min, 26% B at 25 min, 35% B at 30 min,
36% B at 40 min, 70% B at 53 min, 95% B at 56 min, 95% B at
61min, 5%B at 62min, and 5%B at 65min. The absorbance was
recorded at 254, 280, and 320 nm and quantiﬁcation was based
on 12-point linear calibration curves (mean R2 > 0.994) and as a
ratio to the internal standard (i.e. 3,5-dichloro-4-hydroxybenzoic
acid) to account for losses during extraction.
2.3. Study Design
Seven healthy men aged 25–62 years were recruited from the lo-
cal community. Exclusion criteria were as follows: recent (last
3 months) use of antibiotics, ﬂu vaccination, or dietary supple-
ments. All participants gave written informed consent prior to
study commencement and the study was performed at the Hugh
Sinclair Unit of Human Nutrition, University of Reading (UK)
between July 2014 and September 2014. The study was approved
by the University of Reading Research Ethics Committee (Ref-
erence number: 31/15), followed the principles of the Declara-
tion of Helsinki and was registered on ClinicalTrials.gov under
NCT02574039.
The study was designed as a non-blinded, randomized, con-
trolled trial, where participants attended two experimental visits
that were identical with the exception of the two study meals: (1)
test intervention consisting of 60 g oat bran porridge, 200 mL
semi-skimmed milk, and 100 mL water, microwaved (2 min); or
(2) a control consisting of 100 g white bread, 14 g butter, golden
syrup, one boiled egg, and 200 mL semi-skimmed milk; given in
random order. Participants arrived at the Nutrition Unit at 8 am
or 9 am to consume the study meal within 10 min. Urine was
collected at 11 speciﬁc intervals relative to study meal consump-
tion: −12 to 0 h (i.e. baseline), 0 to 2 h, 2 to 4 h, 4 to 6 h, 6 to
8 h, 8 to 12 h, 12 to 24 h, 24 to 28 h, 28 to 32 h, 32 to 36 h, and
36 to 48 h (see Figure 1). Collected urine was kept on ice packs,
the excretion volume measured, and aliquots were stored at
−80 °Cwith andwithout 5% formic acid acidiﬁcation. During the
48 h urine collection period, participants consumed low-phenolic
meals provided to them (lunch: a white bread cheese sandwich
and toﬀee yoghurt; dinner: macaroni cheese pasta, white bread
roll, and cre`me brul´ee; breakfast: white toast with butter and
golden syrup, a boiled egg, and glass of milk), while drinking
water ad libitum. Prior to each experimental visit, participants
followed a diet low in (poly)phenols for 48 h (i.e. no fruits, veg-
etables, wholegrains, pulses, spices, herbs, nuts, seeds, choco-
late, tea, and coﬀee), and attended an overnight fast after hav-
ing consumed a low-(poly)phenol dinner (a cheese pasta bake,
white bread roll, and cre`me brul´ee). Compliance to the dietary
restrictions was assessed using food intake diaries and question-
naires. One volunteer was excluded from the ﬁnal dataset, due to
non-compliance to the dietary restrictions (i.e. volunteer reported
intake of (poly)phenol-rich foods and baseline and post-control
urine contained high levels of phenolics).
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Figure 1. Study design overview.
2.4. Solid Phase Extraction
Phenolic acids were extracted from urine using a validated
method[16] with minor modiﬁcations. Brieﬂy, 1 mL of urine
was spiked with an internal standard (i.e. 3,5-dichloro-4-
hydroxybenzoic acid) and subsequently extracted using SPE car-
tridges (Strata-X columns 500 mg 6mL−1; Phenomenex). These
were washed with 12 mL of 0.1/99.9 v/v hydrochloric acid/water,
dried for 30min under vacuum, soaked in 0.1/99.9 v/v hydrochlo-
ric acid/methanol for 10 min, and eluted into glass vials with 7
mL 0.1/99.9 v/v hydrochloric acid/methanol. Samples were evap-
orated to complete dryness under speedvac at room temperature.
The dried samples were resuspended in 250 μL of mobile phase
(0.1/5/94.9, v/v/v, formic acid/methanol/water) by 30 s vortex-
ing, 15min ultrasound sonicating, and 1 h shaking. Samples were
stored at −80 °C until analysis. For phenolic acids and metabo-
lites the method has a mean ± SD extraction eﬃciency of 88.3 ±
17.8% as previously reported,[16] while we established extraction
eﬃciencies of 102, 97, and 57% for avenanthramide A, B, and C,
respectively.
2.5. UPLC–MS/MS Analysis
The UPLC–ESI–MS/MS system consisted of an Aquity UPLC
Hclass (Waters) coupled to a Xevo TQ-S micro ESI mass spec-
trometer (Waters) operated using MassLynx software (V4.1, Wa-
ters Inc, USA). Compound separation was achieved using an
Aquity UPLCHSS T3 1.8μm column (2.1× 100mm) attached to
a Van guard precolumn of the samematerial and pore size, main-
tained at 45 °C with a ﬂow of 0.65 mL min−1 and a sample injec-
tion volume of 2 μL. The mobile phase consisted of 0.1/99.9 v/v
formic acid/water (A) and 0.1/99.9 v/v formic acid/acetonitrile
(B); and a mobile phase gradient consisting of: 1% B at 0 min,
1% B at 1 min, 30 % B at 10 min, 95 % B at 12 min, 95%
B at 13 min, 1% B at 13.10 min, 1% B at 16 min. A sched-
uled multiple reaction monitoring (sMRM) method was devel-
oped by syringe infusion of 34 analytical standards (see section
Chemicals and Reagents and Supporting Information Table S1)
to determine sMRM transitions, optimal sMRMmodes (i.e. neg-
ative or positive) and collision energies (Supporting Information
Table S2).
Regarding phase II metabolites, while four authentic stan-
dards were used for the sMRM method (i.e. dihydroferulic
acid-4-O-glucuronide, isoferulic acid-3-O-sulfate, ferulic acid-
4-O-glucuronide, and dihydroxybenzoic acid-3-O-glucuronide),
further putative glucuronide or sulfate conjugated phenolic
acid metabolites and feruloyl glycine were added to the sMRM
method, even though analytical standards were not commercially
available. For these, retention times and sMRM transitions were
tentatively identiﬁed by injecting a pooled extract of urine (i.e. us-
ing urine collected after oat bran intake from all n= 7 participants
and during all ten post-intake time intervals). sMRM transitions
were taken from the literature[17–20] or derived from the fragmen-
tation pattern of the phenolic acid aglycones by adding the m/z
of glucuronide (i.e. 176) or sulfate (i.e. 80) to the precursor ion
and including the appropriate MS/MS fragment. Furthermore,
113 m/z, a common fragment of glucuronic acid, was added as
anMS/MS fragment for glucuronide conjugates.[19] Collision en-
ergies were optimized to a limited extent by injecting the pooled
urine extract three times at collision energies−11,−17, and−21
and the best one was selected for each sMRM transition. In the
ﬁnal sMRM, a total of 74 potential compounds were targeted and
statistical comparison between the oat and control intervention
was used to identify those which are oat bran-derived phenolics.
Identiﬁcation of the phenolic metabolites for which standards
were available was based on their retention times and the major
sMRM ion transitions of the standards, while the tentative iden-
tiﬁcation of phenolic metabolites for which analytical standards
were not available was based on 3–6 sMRM ion transitions (ex-
cept for benzoic acid-sulfate which only has two sMRM ion tran-
sitions as reported in the literature[20]) (Supporting Information
Table S2).
Quantiﬁcation was established using the most intense sMRM
transition and 11–14 point calibration curves of analytical stan-
dards (Supporting Information Table S2). Where pure standards
were not available, quantiﬁcation was conducted relative to stan-
dard curves of compounds with similar structures (e.g. the cal-
ibration curve of isoferulic acid-3-O-sulfate was used to quan-
tify all tentatively identiﬁed sulfate metabolites). The LOD and
LOQ were established for each compound as the concentrations
of peaks with S/N of 3 and 10, respectively, and were lowest
for avenanthramide 2p (0.8 and 2.7 nm, respectively) and high-
est for vanillin or hydroxyphenylacetic acid-O-glucuronide (35.0
Mol. Nutr. Food Res. 2018, 62, 1700499 C© 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1700499 (3 of 9)
www.advancedsciencenews.com www.mnf-journal.com
Table 1. Content and composition of phenolics in 60 g oat bran.a)
Fraction
Conjugated and free Bound % Conjugated and free
Avenanthramides
Avenanthramide 2c 0.8 mg [2.5 μmol] ND 100
Avenanthramide 2f 1.0 mg [3.1 μmol] ND 100
Avenanthramide 2p 0.7 mg [2.2 μmol] ND 100
Hydroxycinnamic acids
Ferulic acid 2.0 mg [10.1 μmol] 14.8 mg [76.4 μmol] 12
p-Coumaric acid 0.4mg [2.3 μmol] 3.0 mg [18.1 μmol] 11
Caﬀeic acid 0.1mg [0.4 μmol] 1.3 mg [7.0 μmol] 5
Sinapic acid 0.9 mg [3.8 μmol] 1.2 mg [5.5 μmol] 41
Hydroxybenzoic acids
4-Hydroxybenzoic acid 0.2 mg [1.8 μmol] 0.3 mg [1.9 μmol] 48
Vanillic acid 0.4 mg [2.4 μmol] 0.4 mg [2.2 μmol] 53
Syringic acid 0.4 mg [2.1 μmol] 0.3 mg [1.5 μmol] 57
Benzaldehydes
4-Hydroxybenzaldehyde 0.2 mg [1.4 μmol] 0.1 mg [1.1 μmol] 56
Vanillin ND 0.2 mg [1.3 μmol] 0
Total 7.0 mg [32.1 μmol] 21.6 mg [115.0 μmol] 24
a) 60 g of oat bran porridge made with 200 mL semi-skimmed milk and 100 mL water. Heated by microwave.
ND, not detected.
and 116.7 nm, respectively; Supporting Information Table S2).
Blanks and quality controls were run every ten injections. Vali-
dation parameters indicate that the method had good precision
and repeatability (interday variability: 9.1%; interday variability:
13.7%) and good linearity (linear regression coeﬃcient range:
0.990–1.000; Supporting Information Table S2).
Sample acidiﬁcation using 5% formic acid did not signiﬁcantly
aﬀect phenolic compound peak areas (established in n = 3 vol-
unteers; data not shown) and therefore non-acidiﬁed urine was
used for the complete analysis.
2.6. Statistical Analysis
A two-factor repeated-measurement linear mixed model was ﬁt-
ted to analyze hourly urinary excretion data. The model included
participants nested within time as a random eﬀect and baseline
hourly urinary excretion, intervention, time, and interaction as
ﬁxed eﬀects. When the model showed a signiﬁcant interaction
eﬀect, post-hoc analysis with Tukey–Kramer adjustment was per-
formed. Data are presented as mean ± SEMs. p-values < 0.05
were considered statistically signiﬁcant, and statistical analysis
was performed by using R programming language version 3.1.2
(R Development Core Team, 2014).
3. Results
3.1. Phenolic Composition of the Oat Bran Intervention
Twelve phenolic compounds were detected in the oat bran used
for the trial, with eight phenolic acids being present in both
soluble and bound fractions, three avenanthramides only present
in the soluble fraction and vanillin only in the bound fraction
(Table 1). The intervention diet (60 g oat bran) contained 28.6
mg total phenolics (24% in the soluble fraction), with ferulic
acid being the predominant phenolic acid (16.8 mg) followed by
p-coumaric acid (3.3 mg) and the three avenanthramides collec-
tively amounting to 2.5 mg. Although the control meal and all
othermeals consumed during the 48 h study periods were not an-
alyzed, they consisted of white wheat bread and pasta and would
therefore be expected to contain only low amounts of phenolic
acids.[21]
3.2. Identiﬁcation of Oat Bran-Derived Phenolic Compounds in
Urine
A wide range of phenolic compounds were detected in urine at
baseline and after the control meal intake (Supporting Informa-
tion Table S3). However, the hourly excretion of 30 individual
phenolic compounds was elevated following intake of oat bran
as compared to the control intervention (signiﬁcant mixedmodel
p-value of intervention and/or time*intervention; Supporting In-
formation Table S3), suggesting that they are derived from the
ingested oat bran. These phenolics were identiﬁed as avenan-
thramides 2f and 29 phenolic acids (nine aglycones, four glycine
conjugates, ten sulfate conjugates, and seven glucuronide conju-
gates; Supporting Information Table S2). Excretion of hippuric
acid, the dominant phenolic acid in human urine, was not statis-
tically higher after the oat bran intervention relative to the con-
trol and was thus not identiﬁed as an oat bran-derived metabo-
lites (mixed model time*intervention interaction p-values: 0.36;
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Figure 2. Urinary excretion rate of total 30 oat bran-derived phenolic compounds after intake of 60 g oat bran or a control meal in healthy men (μmol
h−1). Data are reported as mean ± SEM and were analyzed by two-factor repeated measurement linear mixed model with time and intervention as the
two factors [signiﬁcant eﬀect of intervention (p = 0.005), time (p = 3×10−13), and time and intervention interaction (p = 5×10−6)]. Post-hoc analysis
with Tukey–Kramer adjustment was performed and p-values are indicated as follow: * p < 0.05; ** p < 0.01; **** p < 0.0001.
Supporting Information Table S4). In total, 44 targeted phenolic
compoundswere statistically similar between interventions (Sup-
porting Information Table S4).
3.3. Hourly Urinary Excretion of Oat Phenolic Compounds
At baseline, the mean hourly excretion of the total excretion of 30
phenolic compounds prior to oat bran and control interventions
was 2.4 ± 0.6 μmol h−1 and 1.9 ± 0.4 μmol h−1, respectively
(Figure 2). Following intervention, the total hourly phenolic ex-
cretion signiﬁcantly increased at 0–2 h (oat: 9.3 ± 1.9 μmol h−1,
control: 3.1 ± 0.7 μmol h−1; post-hoc p-value <0.0001), returned
to a similar level as control at 2–4 h (oat: 4.7 ± 0.9 μmol h−1,
control: 4.0 ± 1.2 μmol h−1; post-hoc p-value >0.05) and peaked
again between the 4–6 h period (oat: 8.7 ± 1.9μmol h−1, con-
trol: 4.0 ± 0.7μmol h−1; post-hoc p-value < 0.05) and 6–8h (oat:
13.7 ± 1.2 μmol h−1, control: 7.5 ± 0.6 μmol h−1; post-hoc p-
value < 0.01) before returning to a similar level to the control
intervention from 8 to 48 h (post-hoc p-value > 0.05; Figure 2).
Figure 3 shows the oat bran induced increase in excretion of the
individual 30 oat bran-derived phenolics proportional to the total
excretion at 0–2 h, 4–6 h and 6–8 h, relative to control. Vanil-
lic acid, 3-hydroxyhippuric acid, 4-hydroxyhippuric acid, benzoic
acid-O-sulfate and ferulic acid- O-sulfate were the predominant
oat bran-derived phenolics excreted, accounting collectively for
more than two thirds of the total excretion (i.e. 20.3, 16.3, 16.1,
9.8, and 7.3%, respectively). (Iso)ferulic acid-O-sulfate was pre-
dominant during the early 0–2 h peak, vanillic acid was almost ex-
clusively excreted during the late 4–8 h period, while excretion of
hydroxyhippuric acids and benzoic acid-O-sulfate was biphasic,
with early and late peaks (Figure 3). Ferulic acid, p-coumaric acid,
and avenanthramides 2p (i.e. the most abundant phenolic com-
pounds in oats) accounted only for small percentages of the total
excreted phenolics (i.e. 0.21, 0.04, and 0.02%, respectively; Figure
3) and avenanthramide 2f and 2c were not detected, suggesting
that these dietary forms are subject to extensive metabolism.
Themean absolute urinary excretion of the 30 oat bran-derived
phenolics from 0–8 h was 70.7 ± 8.1μmol after consumption
of oat bran and 37.1 ± 4.4 μmol after the control intervention
(Table 2). Hence, on average 22.9 ± 5.0% of the ingested dose
(i.e. 147μmol phenolics in 60 g oat bran; Table 1) was recov-
ered in the 0–8 h urine and there was large inter-individual vari-
ability in absorption that ranged from 3.7 to 41.2 % (Table 2).
The mean percentage recovery of metabolites was lowest for the
avenanthramide 2p (0.3%), intermediate for hydroxycinnamic
acids (6.8–10.7%), and highest for hydroxybenzoic acids (14.5–
159.2%; Table 2).
4. Discussion
The present randomized controlled trial is, to our knowledge, the
ﬁrst to have examined the excretion of phenolic metabolites fol-
lowing intake of dietary amounts of oat bran as a whole food over
a 48 h timeframe and complements previous studies that exam-
ined the metabolism and bioavailability of phenolics following
intake of an oat avenanthramide extract at a high-dose[11] or fol-
lowing intake of wheat.[10] Oat bran intake resulted in elevated
urinary excretion of 30 phenolic compounds at 0–2 h and 4–8 h,
with sulfate or glycine conjugated benzoic acids being the ma-
jor metabolites together with ferulic acid-O-sulfate, and the total
amounts of phenolic compounds recovered in urine amounting
to 22.9 ± 5.0% of the ingested phenolic dose. These results sug-
gest that a high proportion of oat phenolics are bioavailable as a
wide range of metabolites with absorption occurring both in the
small intestine and then in the large intestine within eight hours
of consumption.
Analysis of the utilized oat bran detected nine phenolic acids
amounting to 434 μg g−1 and three avenanthramides amount-
ing to 41 μg g−1 (Table 1). These levels are comparable to four
previous studies that analyzed wholegrain oats or oat bran, iden-
tifying up to ten phenolic acids at levels ranging from 273 to 874
μg g−1 and three avenanthramides at levels ranging from 13 to
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Figure 3. Proportions of individual oat bran-derived phenolics relative to total excretion levels at 0–2 h, 4–6 h, and 6–8 h. Excretion level diﬀerences
between the oat and control interventions were used to calculate percentages.
116 μg g−1.[9,22–24] The relatively wide range in the reported con-
tents and compositions of phenolics can be explained by the dif-
ferent oat products analyzed (i.e. commercial or non-commercial
varieties, bran or wholegrain, and hulled or de-hulled), and by the
diﬀerent extraction and analytical methods used for their anal-
ysis. Although other cereals may be richer sources of phenolic
compounds (for example, Mattila et al. found 6.8-fold and 6.3-
fold more total phenolic compounds in wheat and rye bran, re-
spectively, than in oat bran[23]), oats are particularly interesting
because of the relatively high proportions of phenolics in free
and conjugated forms (24% in our oat bran and from 34 to 62%
in non-commercial hulled wholegrain oats,[9] whereas wheat has
less than 18%[21] andwheat bran cereals only 8%[18]) and thus phe-
nolic components from oats may have a higher bio-accessibility
in comparison to other cereals.
We observed high background excretion of all 30 oat bran-
derived phenolic compounds at baseline and in the control arm
(Supporting Information Table S3; Figure 2), even though vol-
unteers followed a 48 h low-phenolic diet. A high background
phenolic excretion has previously been described in the con-
trol groups of other studies of (poly)phenol bioavailability af-
ter following 2 d[25] or 7 d[26] low phenolic dietary restrictions.
These phenolic compounds may originate from the relatively
low amounts of phenolics consumed in white bread and pasta
during the dietary restrictions[21] and from the metabolism of
other dietary components such as aromatic amino acids.[27] De-
spite this high background excretion, our data indicate that intake
of oat bran leads to urinary excretion of 30 phenolic acid com-
pounds which peak early at 0–2 h, and again later between 4–8 h
(Figure 2). The early appearance of metabolites suggests that
the absorption of free phenolics from the oat bran occurs in the
upper gastrointestinal tract with esteriﬁed conjugates being hy-
drolyzed by esterase activity in the intestinal mucosa,[28] followed
by the transfer of free phenolics across the intestinal epithelium
through passive diﬀusion or via transporters.[29] Although we hy-
pothesized that phenolics in the bound fractionwould appear late
in the urine, due to a requirement for gut microbiota to cleave co-
valent linkages between phenolics and ﬁber, the second peak of
excretion was completed by 8 h, suggesting that the release and
absorption occurred more rapidly (Figure 2). This agrees with
previous studies, showing that bound phenolics may reach the
colon and undergo microbial fermentation within 4 h of oat bran
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Table 2. 0–8 h absolute urinary excretion (μmol) of oat bran-derived phenolics and recovery of ingested dose (%).
Mean ± SEM urinary excretion 0–8 h [μmol] Recovery of ingested dose [%]
Excreted phenolics Control Oat bran Diﬀerence Mean ± SEM Lowest/highest absorber Oat parent compounds (Ingested dose)
Avenanthramide 2p 0.006 ± 0.001 0.012 ± 0.003 0.006 ± 0.003 0.3 ± 0.1 0 /0.7 Avenanthramide 2p [2.2 μmol]
Hydroxycinnamic acids
Ferulic acid metabolitesa) 4.1 ± 0.4 10 ± 0.8 5.9 ± 0.7 6.8 ± 0.8 4.9 /9.3% Ferulic acid [86.5 μmol]
Caﬀeic acid-O-sulfate 0.4 ± 0.2 1.2 ± 0.4 0.8 ± 0.5 10.7 ± 7 −15.6 /34.9 Caﬀeic acid [7.4 μmol]
Sinapic acid-O-sulfate 0.5 ± 0.1 1.5 ± 0.2 1 ± 0.2 10.6 ± 1.6 4.9 /15 Sinapic acid [9.3 μmol]
Hydroxybenzoic acids
(Iso)vanillic acid 6.1 ± 2.5 13.5 ± 3.1 7.3 ± 2.5 159.2 ± 53.8 −80.5 /308.3 Vanillic acid [4.6 μmol]
Benzoic acid-O-sulfate/glucuronide 7.1 ± 2 10.3 ± 2.7 3.2 ± 1 85.2 ± 26 8.1 /176.1 4-hydroxybenzoic acid [3.7 μmol]
Syringic acid-O-sulfate 0.4 ± 0.1 0.9 ± 0.2 0.5 ± 0.1 14.5 ± 4.1 1.5 /30.5 Syringic acid [3.6 μmol]
Total 30 phenolics 37.1 ± 4.4 70.7 ± 8.1 33.7 ± 7.3 22.9 ± 5 3.7 /41.2 Total 12 phenolics [147.1 μmol]
a)Sum of ferulic, isoferulic, dihydroferulic, and dihydroisoferulic acids: aglycones, glucuronides, or sulfates.
intake. Indeed, in fasted volunteers (which was true in our study)
a mean mouth-to-cecum transit time can be as rapid as 2.3 h[30]
and in vitro fermentation of wheat bran with human microbiota
shows that digestion by microbial esterase and xylanase starts
within 2 h resulting inmost ﬁber-bound phenolics being released
within 6 h.[31]
The urinary recovery of ingested phenolics was on average 22.9
± 5.0% in the ﬁrst 8 h after the oat bran intake, relative to the
control (Table 2). Previous non-controlled studies reported lower
mean recoveries in 24 h urine of 4 ± 1, 8 ± 2, and 3 ± 1%
following ingestion of phenolics in wholegrain wheat bread,[10]
aleurone-enriched wheat bread,[10] or wheat bran cereals,[18] re-
spectively, but a higher mean recovery of 29 ± 4% following in-
gestion of phenolics in instant coﬀee.[17] This wide variation in
phenolic bioavailability may partly be explained by diﬀerences in
the bioaccessibility of phenolics within the food matrix. While
phenolic acids in coﬀee are conjugated to quinic acids and are
relatively water soluble,[17] the oat bran used here had 24% solu-
ble phenolic acids (Table 1) and wheat bran cereals only 9%.[18]
However, such direct comparisons of recoveries between studies
may be of limited value due to the non-controlled design of pre-
vious studies,[10,17,18] and diﬀerences in the methods used to ana-
lyze phenolic acids in the urine and food samples including the
number of metabolites targeted with the LC–MS/MS methods.
Possible pathways for the metabolism of 12 ingested
oat phenolic compounds into the 33 excreted urinary com-
pounds are provided in Supporting Information Figure S1
and based on metabolic pathways previously described in the
literature.[17,25,32,33] Notably, the major excreted compounds are
downstream in the metabolic pathways (Figure 3 and Support-
ing Information Figure S1) and therefore products of extensive
metabolism by endogenous and colonic microbial enzymes.
Free forms of vanillic and isovanillic acids were the highest
and seventh most highly excreted phenolics, respectively being
mainly excreted in the late peak between 4–8 h after oat bran in-
take (Figure 3) and at levels totaling more than the total amount
of vanillic acid that was ingested (mean ± SEM recovery: 159.2
± 53.8%; Table 2). These data suggest that while only a limited
amount of vanillic acid is absorbed directly in the small intestine,
a larger proportion is absorbed following release by fermentation
by the colonic microbiota with previous studies suggesting that it
originated partly from the metabolism of avenanthramides and
hydroxycinnamic acids.[25,32,34,35] Vanillic acid may be formed by
β-oxidation of ferulic acid in the liver, and isovanillic acid from
methylation of caﬀeic acid to isoferulic acid followed by liver
β-oxidation (Supporting Information Figure S1).[25,32,34,35] 4-, 3-
and 2-Hydroxyhippuric acids were also highly excreted, with
their excretion following a biphasic pattern (early 0–2 h and late
4–8 h) after oat bran intake (Figure 3). While hydroxyhippuric
acids are common ﬂavonoid metabolites detected, for example,
following intake of orange juice[26] and cocoa,[36] results from this
oat trial and a recent wheat trial[10] suggest that hydroxyhippuric
acids are also important metabolites derived from wholegrain.
A study feeding 75–150 mg avenanthramides in an oat ex-
tract to humans detected nanomolar concentrations of circulat-
ing avenanthramides,[11] while the present study detected only
traces of the ingested 2.5mg avenanthramides in urine. Thismay
indicate that avenanthramides are bioavailable when ingested at a
relatively high dose and that avenanthramides are mostly metab-
olized particularly to hydroxycinnamic acids during their passage
through the gastrointestinal tract and into the circulation (Table
2). Hydroxycinnamic acids, in turn, undergo reduction, methy-
lation, sulfation, or glucuronidation, and are also metabolized to
smaller hydroxybenzoic acids (Table 2, Supporting Information
Figure S1). Chlorogenic acid and caﬀeic acid aglycones in coﬀee
have a similarmetabolic fate to avenanthramides and hydroxycin-
namic acids in cereals. A study in ileostomy patients showed that
although 33% of chlorogenic acid and 95% of caﬀeic acid were
absorbed in the small intestine, only traces of chlorogenic acid
and 11% of caﬀeic acid of the ingested dose were excreted in the
urine.[37] Avenanthramides were also metabolize to hydroxyan-
thralinic acid and dihydroavenanthramides as reported in a study
feeding mice with a high dose of 200 mg kg−1 avenanthramide
2c[12]; however, the present study did determine these two com-
pounds because of poor ionization of the former and unavailabil-
ity of sMRM parameters for the latter.
In conclusion, oats are a popular health food and to our knowl-
edge the present study is the ﬁrst to study themetabolic fate of oat
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avenanthramides and phenolic acids when ingested at a dietary
dose and as a whole food. Our data suggest that oat bran pheno-
lics are more bioavailable than previous studies reported[10,17,18]
with 22.9 ± 5.0% of the ingested dose being excreted in urine
during 8 h following intake in the form of 30 diﬀerent phenolics
or their metabolites. The data showed that benzoic acid deriva-
tives, and in particular (iso)vanillic acid, and three isoforms of
hydroxyhippuric acids, accounted for a high proportion of the
excreted compounds, together with ferulic acid-O-sulfate. While
the present study is an important contribution to the existing lit-
erature, future work is required to verify tentatively identiﬁed
phenolic metabolites against analytical standards, to establish
the detailed pharmacokinetics and circulating concentrations of
these oat bran-derived phenolic compounds, and to determine
their biological activities and contributions to the health beneﬁts
of a diet rich in oats.
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